Platelet dysfunction caused by a novel thromboxane A2 receptor mutation and congenital thrombocytopenia in a case of mild bleeding

Platelets. 2020;31(2):276-279. doi: 10.1080/09537104.2019.1652264. Epub 2019 Aug 7.

Abstract

Chronic hemorrhagic diathesis in patients showing normal levels of plasmatic clotting factors strongly suggests for congenital platelet disorders. We report on a pediatric patient (male, 3 years, D1) with mild bleeding. A sibling (D2), his mother (D3) and father (D4) were included for laboratory investigation. Platelet counts in D1, D2 and D4 indicated mild thrombocytopenia (100 Gpt/L). D1 and D3 platelets showed significantly diminished aggregation response on arachidonic acid and U46619 stimulation. Immunostaining for platelet proteins on blood smears of D1 and D2 indicated defects in ß1-tubulin. Exon sequencing of TBXA2R and TUBB1 revealed heterozygosity for the novel TBXA2R*c.908T>C (p.L303P) mutation in D1 and D3. TUBB1 was either wild type (D2, D3) or heterozygous (D1, D4) for the common polymorphism TUBB1*c.920G>A (rs6070697; p.R307H). In conclusion, the bleeding phenotype of the index patient can be explained by a diminished platelet function caused by the TBXA2R*c.908T>C mutation inherited from the mother and a mild thrombocytopenia with unknown molecular basis that is inherited from the father.

Keywords: Aspirin-like defect; beta1 tubulin; inherited platelet disorder; thrombocytopenia; thromboxane A2 receptor.

Publication types

  • Case Reports

MeSH terms

  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid / pharmacology
  • Adult
  • Arachidonic Acid / pharmacology
  • Blood Platelet Disorders / genetics*
  • Blood Platelet Disorders / metabolism
  • Blood Platelets / drug effects
  • Blood Platelets / metabolism
  • Child, Preschool
  • Female
  • Hemorrhage / genetics*
  • Hemorrhage / metabolism
  • Hemorrhagic Disorders / genetics
  • Hemorrhagic Disorders / metabolism
  • Heterozygote
  • Humans
  • Male
  • Mutation
  • Phenotype
  • Platelet Count
  • Receptors, Thromboxane A2, Prostaglandin H2 / genetics*
  • Receptors, Thromboxane A2, Prostaglandin H2 / metabolism
  • Thrombocytopenia / congenital*
  • Thrombocytopenia / genetics*
  • Thrombocytopenia / metabolism
  • Tubulin / blood
  • Tubulin / genetics

Substances

  • Receptors, Thromboxane A2, Prostaglandin H2
  • TUBB1 protein, human
  • Tubulin
  • Arachidonic Acid
  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid